Adaptive Goal-Directed Adherence Tracking and Enhancement

Completed · Phase 2

Conditions studied: Alcohol Abuse

In brief

Talaria, Inc., has designed an adherence tracking and enhancement system, called AGATE, which uses the text messaging and internet capabilities of modern cellular phones to address the problem of medication adherence in clinical care and clinical trial contexts. This trial will evaluate whether AGATE improves medication adherence in the context of a pharmacotherapy trial of naltrexone to treat problem drinking. All participants will be treatment-seeking problem drinkers who will receive naltrexone and medication monitoring over 8 weeks.

Key facts

Study ID

NCT01349985

Run by

Talaria, Inc

People needed

136

Starts

2011-07-01

Expected to finish

2013-02-01

Last updated by the study team

2014-05-13

Who can join

Age: 21 and older, up to 55. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• problem or heavy drinkers
• age 21-55 years old
• located in the greater Albuquerque NM area
• interested in either reducing or stopping their drinking
• candidates for naltrexone pharmacotherapy

You may not qualify if…

• participation in other naltrexone study
• unable to operate a smartphone
• significant psychiatric or physical illness
• current drug dependence
• current regular opioid use
• any recent nonmedical opioid use
• any lifetime opioid dependence

Where it is running

• The Mind Research Network, University of New Mexico — Albuquerque, New Mexico, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.